Chemoprevention

Heart drug may fight prostate cancer

Digoxin (Lanoxin), a drug long used to treat heart failure and heart rhythm abnormalities, may control prostate cancer.

Read more »

Second BPH drug reduces prostate cancer risk

Like finasteride (Proscar), dutasteride (Avodart), a drug used to treat benign prostatic hyperplasia (BPH), may also reduce the risk of prostate cancer.

Read more »

Can prostate cancer be prevented?

Dr. Ian Thompson, chairman of the Department of Urology at the University of Texas Health Science Center at San Antonio and the principal investigator for the Prostate Cancer Prevention Trial, discusses the trial’s findings and outlines finasteride’s risks and benefits.

Read more »

Data show drug’s benefit in preventing prostate cancer

Despite previous controversy, researchers report that finasteride may reduce overall disease risk and decrease rate of aggressive tumors.

Read more »

BPH drug cleared of causing aggressive tumors

Study finds that finasteride may actually lower the overall risk of prostate cancer and aid in the detection of aggressive tumors. An earlier study had implicated finasteride in the development of these deadlier tumors.

Read more »